Abstract
Purified streptococcal M protein vaccines often produce non-type-specific immunotoxic reactions in the skin or the blood of humans. In an attempt to free the type-specific M antigen (TSM) of such non-type-specific (NTSM) immunotoxic properties, purified M protein preparations were subjected to brief periods (5 to 10 min) of enzymatic digestion in dilute solutions of pepsin (20 mug/ml) at pH 5.0. Such peptic digestion abolished the ability of M protein to aggregate platelets in human platelet-rich plasma and to precipitate plasma fibrinogen. It greatly reduced (up to 16-fold) the capacity of M protein to react with the NTSM complement-fixing antibody that is normally present in human serum. In contrast, it had no effect upon the reactivity of the type-specific M antigen; the pepsin-treated M protein retained its ability to inhibit type-specific streptococcal opsonization by homologous M antibody, and, moreover, retained its ability to elicit type-specific opsonic antibody responses in rabbits.
MeSH Terms
Antibody Formation/drug effects
Bacterial Proteins/isolation & purification,pharmacology
Chromatography, Gel
Complement Fixation Tests
Electrophoresis, Polyacrylamide Gel
Fibrinogen
Hydrogen-Ion Concentration
Immunodiffusion
Pepsin A
Phagocytosis/drug effects
Platelet Adhesiveness/drug effects
Streptococcus pyogenes/analysis,immunology
Chemicals
Bacterial Proteins
Fibrinogen
Pepsin A
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Cunningham M W
Beachey E H
References (16)
16 references, click to expand
-
Antigenicity of the M proteins of group A hemolytic streptococci. 3. Antibody responses and cutaneous hypersensitivity in humans.
J Exp Med. 1966 Dec 1;124(6):1135-51
PMID: 5925319
-
Enhancing effect of type specific antistreptococcal antibodies on emergence of streptococci rich in M-protein.
Proc Soc Exp Biol Med. 1967 Jan;124(1):331-5
PMID: 6018285
-
Prospects for a vaccine against group A streptococci: the problem of the immunology of M proteins.
Arthritis Rheum. 1967 Jun;10(3):245-55
PMID: 5339035
-
Delayed hypersensitivity to purified streptococcal m protein in guinea pigs and in man.
J Immunol. 1969 Jan;102(1):42-52
PMID: 4974697
-
New observations on the structure and antigenicity of the M proteins of the group A streptococcus.
Immunochemistry. 1969 Jan;6(1):11-24
PMID: 4974989
-
Toxic effects of streptococcal M protein on platelets and polymorphonuclear leukocytes in human blood.
J Exp Med. 1971 Aug 1;134(2):351-65
PMID: 4934500
-
An M-associated protein antigen (MAP) of group A streptococci.
J Hyg (Lond). 1971 Dec;69(4):553-64
PMID: 5289717
-
The common antigen(s) of streptococcal M protein vaccines causing hyperimmune reactions in man.
Trans Assoc Am Physicians. 1972;85:212-21
PMID: 4121774
-
Type-specific inhibition of preopsonization versus immunoprecipitation by Streptococcal M proteins.
Infect Immun. 1973 Jul;8(1):19-24
PMID: 4124154
-
Collagen-induced platelet aggregation: involement of an active glycopeptide fragment (alpha1-CB5).
Science. 1973 Aug 17;181(4100):670-2
PMID: 4146780
-
Mediation of cytotoxic effects of streptococcal M protein by nontype-specific antibody in human sera.
J Clin Invest. 1973 Oct;52(10):2563-70
PMID: 4125717
-
Protein measurement with the Folin phenol reagent.
J Biol Chem. 1951 Nov;193(1):265-75
PMID: 14907713
-
Aggregation of blood platelets by adenosine diphosphate and its reversal.
Nature. 1962 Jun 9;194:927-9
PMID: 13871375
-
IMPROVED TECHNIQUE FOR THE PREPARATION OF STREPTOCOCCAL CELL WALLS.
J Bacteriol. 1964 Oct;88:1198-200
PMID: 14219038
-
DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.
Ann N Y Acad Sci. 1964 Dec 28;121:404-27
PMID: 14240539
-
A fibrinogen precipitating factor (FPF) of group A streptococci.
Proc Soc Exp Biol Med. 1959 Oct;102:146-50
PMID: 14404332